Editorial: Improving responses to immunotherapy in glioblastoma multiforme

Front Immunol. 2024 Apr 23:15:1407930. doi: 10.3389/fimmu.2024.1407930. eCollection 2024.

Authors

Stephanie E B McArdle^{1

2}, Divya Nagarajan³, Michael E Barish⁴

Affiliations

¹ John van Geest Cancer Research Centre, Nottingham Trent University, Nottingham, United Kingdom.
² School of Science and Technology, Department of Biosciences, Nottingham Trent University, Nottingham, United Kingdom.
³ Pencil Biosciences Limited, Macclesfield, United Kingdom.
⁴ Department of Stem Cell Biology and Regenerative Medicine, Beckman Research Institute, City of Hope, Duarte, CA, United States.

No abstract available

Keywords: future; glioblastoma multiforme (GBM); immunotherapy; improve; responses.

Publication types

Editorial
Introductory Journal Article
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Brain Neoplasms / immunology
Brain Neoplasms / therapy
Glioblastoma* / immunology
Glioblastoma* / therapy
Humans
Immune Checkpoint Inhibitors / therapeutic use
Immunotherapy* / methods
Treatment Outcome

Substances

Immune Checkpoint Inhibitors